Add BrightSurf on Google Email

University of Birmingham


Women who have gestational diabetes in pregnancy are at higher risk of future health issues

Research found that women diagnosed with GDM were over 20 times more likely to develop type 2 diabetes, nearly twice as likely to develop hypertension, and almost twice as likely to develop ischemic heart disease. The study highlights the need for targeted risk factor management to improve long-term metabolic and cardiovascular outcomes.

SourceUniversity of Birmingham·JournalPLOS Medicine·DateJan 16, 2018

Children with heart disease are being let down by lack of clinical trials, study finds

A UK study found that less than one per cent of children born with congenital heart disease participate in clinical trials, highlighting a need for improved treatment options. Researchers suggest establishing a congenital heart disease research network to conduct well-designed clinical trials and improve surgical outcomes.

SourceUniversity of Birmingham·JournalEuropean Journal of Cardio-Thoracic Surgery·DateNov 22, 2017

Call for Europe-wide screening of babies for heart defects

A consensus statement from a group of neonatologists and pediatric cardiologists recommends routine pulse oximetry screening for all European babies within 24 hours of birth to detect critical congenital heart defects. Early detection is crucial for the best outcome, and current methods may miss up to 50% of affected infants.

SourceUniversity of Birmingham·JournalThe Lancet Child & Adolescent Health·DateNov 7, 2017

Clinical trial reveals genetic fault that reduces the effectiveness of leukemia treatment

A genetic fault in the CDKN2A gene has been linked to reduced effectiveness of leukemia treatment, highlighting the need for personalized treatment approaches. The study, which treated 259 people with AML or MDS, found that those with the mutation survived for 4.5 months on average, compared to 11 months for those without it.

SourceUniversity of Birmingham·JournalClinical Cancer Research·DateSep 26, 2017

Scientists discover common obesity and diabetes drug reduces rise in brain pressure

Researchers at the University of Birmingham have discovered that GLP-1 agonist extendin-4 significantly reduces brain pressure in an animal model, with effects lasting at least 24 hours. The treatment shows promise as a novel new way to lower brain pressure, potentially benefiting patients with conditions such as traumatic brain injury...

SourceUniversity of Birmingham·JournalScience Translational Medicine·DateAug 23, 2017

Study uncovers link between male hormones and metabolic disease in polycystic ovary syndrome

Researchers at the University of Birmingham have discovered that increased male hormones, particularly AKR1C3 enzyme activity in fat tissue, drive PCOS women's risk to develop diabetes and fatty liver disease. Abdominal fat tissue is a major source of high levels of male hormones in women with PCOS.

SourceUniversity of Birmingham·JournalThe Journal of Clinical Endocrinology & Metabolism·DateJun 22, 2017